Individuals with CHIP have been shown to have increased risks of developing myeloid malignancies such as leukemia and myelodysplastic syndrome (MDS), CVDs, and various inflammatory diseases [34]. This evidence concerns the gene STUB1 and myelodysplastic syndrome.